If your insurance denied Wegovy or Zepbound, you are in very good company, and the denial is almost never the end of the story. Weight-management GLP-1s are among the most frequently denied prescriptions in the United States, yet a large share of those denials get overturned once someone actually appeals. This guide walks you through why insurers say no, what to gather, how to write the appeal, and what to do while you wait.
Why insurance denied Wegovy or Zepbound in the first place
Start with the denial letter. By law it has to state the specific reason for the denial, your appeal rights, and your deadline. Most GLP-1 denials fall into one of four buckets:
- Plan exclusion. Your plan simply does not cover weight-management drugs at all. This is the hardest one to beat, but not impossible if you have a second qualifying condition (see below).
- Prior authorization criteria not met. The insurer wants a documented BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, sleep apnea, or prediabetes. If your chart is missing a recent BMI or a diagnosis code, the request gets bounced.
- Step therapy. The plan wants proof you tried a lower-cost option first, or completed a supervised lifestyle program for a set number of months.
- Not medically necessary. A catch-all that usually means the paperwork did not tell a convincing story. Strong documentation fixes this more often than not.
Consequently, the single most important thing you can do is match your appeal to the exact reason on the letter. A great letter that argues the wrong point still loses.
Step 1: Call and ask what is missing
Before you write anything, call the number on the denial letter and ask two questions: “What specific criteria were not met?” and “What documentation would satisfy them?” Surprisingly often, the answer is something simple, such as a missing lab value or a BMI that was recorded in the wrong place. Your prescriber’s office can resubmit the prior authorization with the missing piece, and the denial disappears without a formal appeal.
Also confirm your deadline. Under federal rules, you generally have up to 180 days from the denial notice to file an internal appeal, but some plans set shorter windows. Write the date down.
Step 2: Gather the evidence that wins appeals
Insurance reviewers respond to numbers and dates, not feelings. When insurance denied Wegovy or Zepbound for “criteria not met,” it is usually because one of the items below was missing. Pull together:
- Height, weight, and BMI history over at least the past 6 to 12 months, ideally from clinic visits.
- Weight-related diagnoses with ICD-10 codes: hypertension, type 2 diabetes or prediabetes, obstructive sleep apnea, high cholesterol, fatty liver disease, PCOS, or osteoarthritis.
- Prior attempts to lose weight: diet programs, dietitian visits, exercise plans, and any earlier medications, with dates and results.
- Current medication response if you are already on treatment and the denial is for a refill or a dose increase. Weight lost so far, improvements in blood pressure or A1c, and side effects you tolerated are all persuasive.
This is where a good log pays off. If you have been recording your doses, weight, and side effects, you can hand your prescriber a clean timeline instead of trying to reconstruct it from memory. Many people track it free with Pep, then export or screenshot the weight trend and dose history for the appeal packet.
Step 3: Write the appeal letter (and get a letter of medical necessity)
Your appeal has two parts: a short letter from you and a letter of medical necessity from your prescriber. Keep yours factual and organized:
- Your name, member ID, claim or reference number, and the date of the denial.
- One sentence stating that you are appealing and which medication and dose you are requesting.
- The insurer’s stated reason for denial, quoted directly from the letter.
- A point-by-point response showing how you meet each criterion, with the supporting documents attached.
- The health risks of not treating obesity in your case, and how the medication addresses them.
- A closing request for a written decision within the plan’s required timeframe.
Novo Nordisk publishes a sample Wegovy patient coverage request letter you can adapt, and Lilly offers similar coverage resources for Zepbound. Your prescriber’s letter of medical necessity should cite the FDA-approved indication, your qualifying BMI and conditions, and, when relevant, the cardiovascular risk-reduction data for semaglutide or the sleep apnea indication for tirzepatide. Ask for a peer-to-peer review as well; a direct conversation between your doctor and the plan’s medical director resolves a surprising number of denials.
Step 4: Escalate to external review if the internal appeal fails
If the plan upholds its decision and insurance denied Wegovy a second time, you are not done. Most plans created after March 2010 must offer an independent external review, in which a reviewer with no ties to the insurer makes a binding decision. You generally have four months from the final internal denial to request it, and standard reviews are decided within 45 days (expedited reviews within 72 hours if your health is at risk). External reviews overturn denials at a meaningfully higher rate than internal ones, because the reviewer is judging medical necessity, not the plan’s budget.
If your coverage is through an employer, HR or the benefits team can sometimes intervene directly, especially if the denial contradicts what the plan documents promise. And if you are on Medicare, the Medicare GLP-1 coverage rules have their own five-level appeal process worth reading separately.
What to do while you wait
Appeals take weeks, and stopping a GLP-1 abruptly can bring hunger and weight back quickly. If insurance denied Wegovy or Zepbound mid-treatment, a few practical options can bridge the gap:
- Ask about a temporary supply. Some plans grant a 30-day transition fill during an appeal, particularly if you are already established on the medication.
- Check self-pay pricing. Manufacturer self-pay programs and the TrumpRx channel have pushed cash prices well below list. Our GLP-1 cost guide has current numbers, and the free GLP-1 cost calculator lets you compare a month of self-pay against your expected copay so you know what the appeal is actually worth.
- Do not stretch doses without talking to your prescriber. If a gap is unavoidable, ask whether a lower maintenance dose or a planned restart is safer than an unplanned stop.
- Watch for coverage changes. Formularies shift every year. The CVS Caremark Zepbound return on October 1 is a good example, and if your employer is dropping GLP-1 coverage in 2027, this open enrollment season is the time to compare plans.
Insurance denied Wegovy or Zepbound: quick FAQ
How often are Wegovy and Zepbound appeals successful?
It varies by plan and by how well the denial reason is addressed, but “insurance denied Wegovy” is rarely the final answer. Published estimates for GLP-1 appeals range from roughly 40 percent to well over half when the packet includes a letter of medical necessity, documented BMI and comorbidities, and a record of prior weight-loss attempts. Denials for simple missing paperwork are overturned far more often than plan-wide exclusions.
Can I appeal if my plan excludes weight-loss drugs entirely?
You can, though the odds are lower. The strongest angle is a second FDA-approved indication: Wegovy is approved to reduce cardiovascular risk in adults with heart disease and obesity, and Zepbound is approved for moderate to severe obstructive sleep apnea in adults with obesity. If you qualify under one of those, ask your prescriber to submit under that diagnosis rather than weight management.
How long does a GLP-1 insurance appeal take?
Plans must generally decide a standard internal appeal for a drug you have not yet received within 30 days, and an urgent appeal within 72 hours. External review adds up to 45 days. Calling to confirm receipt and asking for the expected decision date keeps the clock honest.
This article is for educational purposes only and is not medical, legal, or insurance advice. Talk with your prescriber and your health plan about your specific situation.




